COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Prostacyclin is one of a number of lipid mediators elaborated from the metabolism of arachidonic acid by the cyclooxygenase (COX) enzymes. This prostanoid is a potent inhibitor of platelet aggregation, and its production by endothelial cells and protective role in the vasculature are well established. In contrast, much less is known regarding the function of this prostanoid in other disease processes. We show here that COX-2-dependent production of prostacyclin plays an important role in the development of fibrotic lung disease, limiting both the development of fibrosis and the consequential alterations in lung mechanics. In stark contrast, loss of prostaglandin E 2 synthesis and signaling through the G s-coupled EP2 and EP4 receptors had no effect on the development of disease. These findings suggest that prostacyclin analogs will protect against bleomycin-induced pulmonary fibrosis in COX-2−/−mice. If such protection is observed, investigation of these agents as a novel therapeutic approach to pulmonary fibrosis in humans may be warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M., & Kudo, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003504200 · Cited by 708 · cited 1×
“Microsomal PGE2 synthase 2 and cytosolic PGE2 synthase increase PGE2 production when overexpressed in various cell lines (34, 52).”
BackgroundKolodsick, J. E., Peters-Golden, M., Larios, J., Toews, G. B., Thannickal, V. J., & Moore, B. B. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0243oc · Cited by 294 · cited 2×
“Other studies have shown that PGE2 is capable of inhibiting fibroblast migration and fibroblast to myofibroblast transition (26, 28).”
BackgroundBitterman, P. B., Wewers, M. D., Rennard, S. I., Adelberg, S., & Crystal, R. G. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112364 · Cited by 232 · cited 1×
“Ex vivo studies have shown that PGE2 can decrease proliferation and suppress collagen synthesis of lung fibroblasts (3, 9, 13, 14, 18, 31).”
BackgroundCruz-Gervis, R., Stecenko, A. A., Dworski, R., Lane, K. B., Loyd, J. E., Pierson, R., King, G., & Brigham, K. L. (2002) · Respiratory Research · doi:10.1186/rr166 · Cited by 38 · cited 1×
“PGIS expression has been demonstrated on pneumocytes, fibroblasts, endothelial cells, and resident leukocytes, and IP expression has been demonstrated on pneumocytes, fibroblasts, smooth muscle cells, and macrophages (12, 27, 40, 42, 44, 55).”
Background
Cited by
Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression
Liu, F., Mih, J. D., Shea, B. S., Kho, A. T., Sharif, A. S., Tager, A. M., & Tschumperlin, D. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201004082 · Cited by 810
Woodward, D. F., Jones, R. L., & Narumiya, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003517 · Cited by 443
Cytosolic phospholipase A2: physiological function and role in disease
Leslie, C. C. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r057588 · Cited by 413
Prostaglandins and chronic inflammation
Aoki, T., & Narumiya, S. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.02.004 · Cited by 291
Prostaglandin‐cytokine crosstalk in chronic inflammation
Yao, C., & Narumiya, S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14530 · Cited by 283
Metadata
- Authors
- Lovgren, A. K., Jania, L. A., Hartney, J. M., Parsons, K. K., Audoly, L. P., FitzGerald, G. A., Tilley, S. L., & Koller, B. H.
- Venue
- American Journal of Physiology-Lung Cellular and Molecular Physiology
- Publisher
- American Physiological Society
- Published
- 2006-08
- Volume
- 291
- Issue
- 2
- Pages
- L144-L156
- ISSN
- 1040-0605 (ISSN-L)
- 1522-1504
- OpenAlex
- W2124495536
- Cited by
- 128
- References
- 4
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis. https://app.cochat.ai/papers/10.1152/ajplung.00492.2005
- The paper
- Lovgren, A. K., Jania, L. A., Hartney, J. M., Parsons, K. K., Audoly, L. P., FitzGerald, G. A., Tilley, S. L., & Koller, B. H. (2006). COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. https://doi.org/10.1152/ajplung.00492.2005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.